- 1-888-253-3960
- enquiry@vynzresearch.com
-
This is lorem ipsum doller
Digital Biomarkers Market
| Status : Published | Published On : Dec, 2023 | Report Code : VRHC1235 | Industry : Healthcare | Available Format :
|
Page : 280 |
Global Digital Biomarkers Market – Analysis and Forecast (2025-2030)
Industry Insight by System Component (Data Collection Tools (Digital Platforms, Mobile Apps, Desktop-Based Software, Wearable, and Biosensors) and Data Integration Systems), by Therapeutic Area (Cardiovascular Diseases, Neurodegenerative Disorders, Sleep and Movement Diseases, Psychiatric Disorders, Chronic Pain, Gastrointestinal Diseases, Diabetes, Respiratory Diseases, and Others), by Application (Wellness, Disease Diagnosis, Personalized Medication, and Drug Discovery and Development), by Development Status (Novel Digital Biomarkers, Original Digital Biomarkers, and Approved Digital Biomarkers), by End-User (Pharmaceutical Companies & Labs, Healthcare Providers, and Insurance Payers),and Geography (U.S., Canada, Germany, U.K., France, China, Japan, India, and Rest of the World)
Industry Overview
The Global Digital Biomarkers Market is expected to grow from USD 0.86 billion to USD 5.4 billion by 2030 at a CAGR of 22.5% during the forecast period ranging from 2025 to 2030.
Digital biomarkers use digital technologies, such as sensors, wearable devices, and mobile applications, to collect and analyze physiological, behavioral, and environmental data to evaluate an individual's health condition. These devices also help in monitoring the progress of a disease by measuring and tracking different pathological and anatomical features of an individual. Especially helpful for patients suffering from chronic diseases, the biomarkers help in providing quality healthcare by doctors who can track and measure the symptoms of the patient early. These are also used extensively in clinical care and clinical trials.
The growth of the global digital biomarkers market is the result of higher penetration of smartphones and the use of health-related mobile apps, as well as the rise in acceptance and use of connected digital devices. The significant development of wearable devices also promotes market growth.
The growth of the global digital biomarkers market is somewhat hindered by the growing concerns over data privacy and security breaches. The rise in the demand for data-driven, more efficient, and customized healthcare solutions is however creating promising growth opportunities for the market.
Market Segmentation
Insight by System Component
The global digital biomarkers market is divided by system components into data collection tools and data integration systems segments, where the former is further divided into digital platforms, mobile apps, desktop-based software, wearable, and biosensors and will grow more due to the penetration of digital tools like smartphones and wearables to collect health information.
Insight by Therapeutic Area
The global digital biomarkers market is also split by therapeutic area into cardiovascular diseases, neurodegenerative disorders, sleep and movement diseases, psychiatric disorders, chronic pain, gastrointestinal diseases, diabetes, respiratory diseases, and other segments. Among all these segments, the cardiovascular diseases segment will grow more due to the provision of in-depth insights into the response of a cardiac patient during standardized activity. It also helps in improving cardiac rehab outcomes. However, the chronic pain segment is expected to grow at a faster rate during the forecast period due to the development and adoption of AR and VR solutions for finding and treating chronic pain.
Insight by Application
According to the application, the global digital biomarkers market is segmented into wellness, disease diagnosis, personalized medication, and drug discovery and development segments. Out of all these segments, the drug discovery and development segment will grow at a higher CAGR due to the growing adoption of AI cloud-based services in the pharmaceutical industry to allow cost-effective and efficient drug discovery.
Insight by Development Status
The global digital biomarkers market is also divided by development status into novel digital biomarkers, original digital biomarkers, and approved digital biomarkers segments. Out of these segments, the approved digital biomarkers segment is expected to grow more in terms of revenue during the forecast period due to higher reliability and legal authenticity being FDA-approved.
Insight by End-User
End users also divide the global digital biomarkers market into pharmaceutical companies & labs, healthcare providers, and insurance payers’ categories. Out of these segments, the pharmaceutical companies will grow more and contribute the largest share due to their contribution to the development of drugs by providing novel data for researchers to understand the progression of the disease and understand the performance or response of the patients towards the drugs. This helps pharmaceutical companies develop customized drugs according to the specifications of patients, pushing demand and growth.
Global Digital Biomarkers Market Report Coverage
|
Report Metric |
Details |
|
Historical Period |
2018 - 2023 |
|
Base Year Considered |
2024 |
|
Forecast Period |
2025 - 2030 |
|
Market Size in 2023 |
U.S.D. 0.86 Billion |
|
Revenue Forecast in 2030 |
U.S.D. 5.4 Billion |
|
Growth Rate |
22.5% |
|
Segments Covered in the Report |
By System Component, By Therapeutic Area, By Application, By Development Status and By End-User |
|
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
|
Regions Covered in the Report |
North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World |
Industry Dynamics
Industry Trends
There is a growing acceptance of 3G, 4G, and other high-speed networks, and significant developments noticed in information technology apart from facilitating the use of these solutions. In addition, the growing demand for these systems is also reducing the cost of healthcare significantly. These solutions are also used extensively to treat persistently ill patients. In addition, there is a surge in the use of wearable devices, such as smartwatches and fitness trackers, for disease management and health monitoring.
Growth Drivers
The existence of a large number of major industry players and their continual effort to develop their products and make new launches fuel the market growth significantly. Supportive government initiatives, speedy FDA approval, the need for alternatives due to the failure of drugs for neurodegenerative disorders, growing mental and other health issues, diabetes, cardiovascular diseases, and BP are some other factors that push the market forward.
Challenges
Typically, the strict government regulations coupled with the stringent standardization procedures hinder the growth of the digital biomarkers market. Furthermore, the lack of proper training to handle the systems and the absence of strategic planning and coordination hinders the market growth.
Opportunities
The potential to improve healthcare outcomes by facilitating early disease detection, the advent of tailored medicine, and higher investment in wearable technology and voice-based digital biomarkers offer novel growth opportunities to the global digital biomarkers market.
Geographic Overview
North America will lead the market with its largest share during the forecast period due to the existence of a large number of prominent industry players launching newer and better products, higher investment in R&D, and rising approval of smart devices.
Asia Pacific is expected to grow at a faster rate due to the growing importance of government in improving healthcare infrastructure, the growing adoption of smart devices, and the rise in the number of chronic disease incidents in the region.
Competitive Insight
The industry Players are focusing on R&D in product development and want to build their brand value. Various other strategies such as mergers and acquisitions, collaborating with research and medical institutions, and expanding their presence in the digital biomarkers market.
AliveCor Labs' digital tools help patients access, manage and share their data, and connect with cardiologists to better understand and manage their heart health.
Digital and video resources are available on biomarker testing for solid tumors and hematology, as well as a comprehensive precision medicine digital binder in Novartis AG.
Some of the key players operating in the global digital biomarkers market are AliveCor Labs, Eli Lilly and Company, Biogen, Novartis AG, Fitbit LLC, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Pfizer Inc., and Takeda Pharmaceutical Company Limited.
Recent Developments by Key Players
Novartis has received approval from the US Food and Drug Administration (FDA) for commercial manufacturing of Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) at its new large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.
Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson's disease. As part of the agreement, Biogen will licence Konectom to Indivi, a smartphone-based digital biomarker platform that assesses neurological functions remotely for more precise, frequent measurement of disease evolution.
The Digital Biomarkers Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.
Segments Covered in the Report
- By System Component
- Data Collection Tools
- Digital Platforms
- Mobile Apps
- Desktop-Based Software
- Wearable
- Biosensors
- Data Integration Systems
- Data Collection Tools
- By Therapeutic Area
- Cardiovascular Diseases
- Neurodegenerative Disorders
- Sleep and Movement Diseases
- Psychiatric Disorders
- Chronic Pain
- Gastrointestinal Diseases
- Diabetes
- Respiratory Diseases
- Others
- By Application
- Wellness
- Disease Diagnosis
- Personalized Medication
- Drug Discovery and Development
- By Development Status
- Novel Digital Biomarkers
- Original Digital Biomarkers
- Approved Digital Biomarkers
- By End-User
- Pharmaceutical Companies & Labs
- Healthcare Providers
- Insurance Payers
Region Covered in the Report
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World (RoW)
- Brazil
- Saudi Arabia
- South Africa
- U.A.E.
- Other Countries
.png "Digital Biomarkers Market Size")
Source: VynZ Research
Source: VynZ Research
1. Research Overview
1.1. The Report Offers
1.2. Market Coverage
1.2.1. By System Component
1.2.2. By Therapeutic Area
1.2.3. By Application
1.2.4. By Development Status
1.2.5. By End-User
1.2.6. By Region
1.3. Research Phases
1.4. Limitations
1.5. Market Methodology
1.5.1. Data Sources
1.5.1.1. Primary Research
1.5.1.2. Secondary Research
1.5.2. Methodology
1.5.2.1. Data Exploration
1.5.2.2. Forecast Parameters
1.5.2.3. Data Validation
1.5.2.4. Assumptions
1.5.3. Study Period & Data Reporting Unit
2. Executive Summary
3. Industry Overview
3.1. Industry Dynamics
3.1.1. Market Growth Drivers
3.1.2. Market Restraints
3.1.3. Key Market Trends
3.1.4. Major Opportunities
3.2. Industry Ecosystem
3.2.1. Porter’s Five Forces Analysis
3.2.2. Recent Development Analysis
3.2.3. Value Chain Analysis
3.3. Competitive Insight
3.3.1. Competitive Position of Industry Players
3.3.2. Market Attractive Analysis
3.3.3. Market Share Analysis
4. Global Market Estimate and Forecast
4.1. Global Market Overview
4.2. Global Market Estimate and Forecast to 2030
5. Market Segmentation Estimate and Forecast
5.1. By System Component
5.1.1. Data Collection Tools
5.1.1.1. Market Definition
5.1.1.2. Market Estimation and Forecast to 2030
5.1.1.2.1. Digital Platforms
5.1.1.2.2. Mobile Apps
5.1.1.2.3. Desktop-Based Software
5.1.1.2.4. Wearable
5.1.1.2.5. Biosensors
5.1.2. Data Integration Systems
5.1.2.1. Market Definition
5.1.2.2. Market Estimation and Forecast to 2030
5.2. By Therapeutic Area
5.2.1. Cardiovascular Diseases
5.2.1.1. Market Definition
5.2.1.2. Market Estimation and Forecast to 2030
5.2.2. Neurodegenerative Disorders
5.2.2.1. Market Definition
5.2.2.2. Market Estimation and Forecast to 2030
5.2.3. Sleep and Movement Diseases
5.2.3.1. Market Definition
5.2.3.2. Market Estimation and Forecast to 2030
5.2.4. Psychiatric Disorders
5.2.4.1. Market Definition
5.2.4.2. Market Estimation and Forecast to 2030
5.2.5. Chronic Pain
5.2.5.1. Market Definition
5.2.5.2. Market Estimation and Forecast to 2030
5.2.6. Gastrointestinal Diseases
5.2.6.1. Market Definition
5.2.6.2. Market Estimation and Forecast to 2030
5.2.7. Diabetes
5.2.7.1. Market Definition
5.2.7.2. Market Estimation and Forecast to 2030
5.2.8. Respiratory Diseases
5.2.8.1. Market Definition
5.2.8.2. Market Estimation and Forecast to 2030
5.2.9. Others
5.2..1. Market Definition
5.2.9.2. Market Estimation and Forecast to 2030
5.3. By Application
5.3.1. Wellness
5.3.1.1. Market Definition
5.3.1.2. Market Estimation and Forecast to 2030
5.3.2. Disease Diagnosis
5.3.2.1. Market Definition
5.3.2.2. Market Estimation and Forecast to 2030
5.3.3. Personalized Medication
5.3.3.1. Market Definition
5.3.3.2. Market Estimation and Forecast to 2030
5.3.4. Drug Discovery and Development
5.3.4.1. Market Definition
5.3.4.2. Market Estimation and Forecast to 2030
5.4. By Development Status
5.4.1. Novel Digital Biomarkers
5.4.1.1. Market Definition
5.4.1.2. Market Estimation and Forecast to 2030
5.4.2. Original Digital Biomarkers
5.4.2.1. Market Definition
5.4.2.2. Market Estimation and Forecast to 2030
5.4.3. Approved Digital Biomarkers
5.4.3.1. Market Definition
5.4.3.2. Market Estimation and Forecast to 2030
5.5. By End-User
5.5.1. Pharmaceutical Companies & Labs
5.5.1.1. Market Definition
5.5.1.2. Market Estimation and Forecast to 2030
5.5.2. Healthcare Providers
5.5.2.1. Market Definition
5.5.2.2. Market Estimation and Forecast to 2030
5.5.3. Insurance Payers
5.5.3.1. Market Definition
5.5.3.2. Market Estimation and Forecast to 2030
6. North America Market Estimate and Forecast
6.1. By System Component
6.2. By Therapeutic Area
6.3. By Application
6.4. By Development Status
6.5. By End-User
6.6. By Country
6.6.1. U.S. Market Estimate and Forecast
6.6.2. Canada Market Estimate and Forecast
6.6.3. Mexico Market Estimate and Forecast
7. Europe Market Estimate and Forecast
7.1. By System Component
7.2. By Therapeutic Area
7.3. By Application
7.4. By Development Status
7.5. By End-User
7.6. By Country
7.6.1. Germany Market Estimate and Forecast
7.6.2. France Market Estimate and Forecast
7.6.3. U.K. Market Estimate and Forecast
7.6.4. Italy Market Estimate and Forecast
7.6.5. Spain Market Estimate and Forecast
7.6.6. Rest of Europe Market Estimate and Forecast
8. Asia-Pacific Market Estimate and Forecast
8.1. By System Component
8.2. By Therapeutic Area
8.3. By Application
8.4. By Development Status
8.5. By End-User
8.6. By Country
8.6.1. China Market Estimate and Forecast
8.6.2. Japan Market Estimate and Forecast
8.6.3. India Market Estimate and Forecast
8.6.4. South Korea Market Estimate and Forecast
8.6.5. Singapore Market Estimate and Forecast
8.6.6. Rest of Asia-Pacific Market Estimate and Forecast
9. Rest of the World (RoW) Market Estimate and Forecast
9.1. By System Component
9.2. By Therapeutic Area
9.3. By Application
9.4. By Development Status
9.5. By End-User
9.6. By Country
9.6.1. Brazil Market Estimate and Forecast
9.6.2. Saudi Arabia Market Estimate and Forecast
9.6.3. South Africa Market Estimate and Forecast
9.6.4. Other Countries Market Estimate and Forecast
10. Company Profiles
10.1. AliveCor Labs
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
10.2. Eli Lilly and Company
10.2.1. Snapshot
10.2.2. Overview
10.2.3. Offerings
10.2.4. Financial Insight
10.2.5. Recent Developments
10.3. Biogen
10.3.1. Snapshot
10.3.2. Overview
10.3.3. Offerings
10.3.4. Financial Insight
10.3.5. Recent Developments
10.4. Novartis AG
10.4.1. Snapshot
10.4.2. Overview
10.4.3. Offerings
10.4.4. Financial Insight
10.4.5. Recent Developments
10.5. Fitbit LLC
10.5.1. Snapshot
10.5.2. Overview
10.5.3. Offerings
10.5.4. Financial Insight
10.5.5. Recent Developments
10.6. GlaxoSmithKline plc
10.6.1. Snapshot
10.6.2. Overview
10.6.3. Offerings
10.6.4. Financial Insight
10.6.5. Recent Developments
10.7. F. Hoffmann-La Roche Ltd
10.7.1. Snapshot
10.7.2. Overview
10.7.3. Offerings
10.7.4. Financial Insight
10.7.5. Recent Developments
10.8. Koninklijke Philips N.V.
10.8.1. Snapshot
10.8.2. Overview
10.8.3. Offerings
10.8.4. Financial Insight
10.8.5. Recent Developments
10.9. Pfizer Inc.
10.9.1. Snapshot
10.9.2. Overview
10.9.3. Offerings
10.9.4. Financial Insight
10.9.5. Recent Developments
10.10. Takeda Pharmaceutical Company Limited
10.10.1. Snapshot
10.10.2. Overview
10.10.3. Offerings
10.10.4. Financial Insight
10.10.5. Recent Developments
11. Appendix
11.1. Exchange Rates
11.2. Abbreviations
Note: Financial insight and recent developments of different companies are subject to availability of information in secondary domain.
List of Tables
Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Digital Biomarkers Market Size, By System Component, 2018 - 2023 (USD Billion)
Table 5 Global Digital Biomarkers Market Size, By System Component, 2025 - 2030 (USD Billion)
Table 6 Global Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2023 (USD Billion)
Table 7 Global Digital Biomarkers Market Size, By Therapeutic Area, 2025 - 2030 (USD Billion)
Table 8 Global Digital Biomarkers Market Size, By Application, 2018 - 2023 (USD Billion)
Table 9 Global Digital Biomarkers Market Size, By Application, 2025 - 2030 (USD Billion)
Table 10 Global Digital Biomarkers Market Size, By Development Status, 2018 - 2023 (USD Billion)
Table 11 Global Digital Biomarkers Market Size, By Development Status, 2025 - 2030 (USD Billion)
Table 12 Global Digital Biomarkers Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 13 Global Digital Biomarkers Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 14 Global Digital Biomarkers Market Size, by Region, 2018 - 2023 (USD Billion)
Table 15 Global Digital Biomarkers Market Size, by Region, 2025 - 2030 (USD Billion)
Table 16 North America Digital Biomarkers Market Size, By System Component, 2018 - 2023 (USD Billion)
Table 17 North America Digital Biomarkers Market Size, By System Component, 2025 - 2030 (USD Billion)
Table 18 North America Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2023 (USD Billion)
Table 19 North America Digital Biomarkers Market Size, By Therapeutic Area, 2025 - 2030 (USD Billion)
Table 20 North America Digital Biomarkers Market Size, By Application, 2018 - 2023 (USD Billion)
Table 21 North America Digital Biomarkers Market Size, By Application, 2025 - 2030 (USD Billion)
Table 22 North America Digital Biomarkers Market Size, By Development Status, 2018 - 2023 (USD Billion)
Table 23 North America Digital Biomarkers Market Size, By Development Status, 2025 - 2030 (USD Billion)
Table 24 North America Digital Biomarkers Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 25 North America Digital Biomarkers Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 26 North America Digital Biomarkers Market Size, by Region, 2018 - 2023 (USD Billion)
Table 27 North America Digital Biomarkers Market Size, by Region, 2025 - 2030 (USD Billion)
Table 28 Europe Digital Biomarkers Market Size, By System Component, 2018 - 2023 (USD Billion)
Table 29 Europe Digital Biomarkers Market Size, By System Component, 2025 - 2030 (USD Billion)
Table 30 Europe Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2023 (USD Billion)
Table 31 Europe Digital Biomarkers Market Size, By Therapeutic Area, 2025 - 2030 (USD Billion)
Table 32 Europe Digital Biomarkers Market Size, By Application, 2018 - 2023 (USD Billion)
Table 33 Europe Digital Biomarkers Market Size, By Application, 2025 - 2030 (USD Billion)
Table 34 Europe Digital Biomarkers Market Size, By Development Status, 2018 - 2023 (USD Billion)
Table 35 Europe Digital Biomarkers Market Size, By Development Status, 2025 - 2030 (USD Billion)
Table 36 Europe Digital Biomarkers Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 37 Europe Digital Biomarkers Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 38 Europe Digital Biomarkers Market Size, by Region, 2018 - 2023 (USD Billion)
Table 39 Europe Digital Biomarkers Market Size, by Region, 2025 - 2030 (USD Billion)
Table 40 Asia-Pacific Digital Biomarkers Market Size, By System Component, 2018 - 2023 (USD Billion)
Table 41 Asia-Pacific Digital Biomarkers Market Size, By System Component, 2025 - 2030 (USD Billion)
Table 42 Asia-Pacific Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2023 (USD Billion)
Table 43 Asia-Pacific Digital Biomarkers Market Size, By Therapeutic Area, 2025 - 2030 (USD Billion)
Table 44 Asia-Pacific Digital Biomarkers Market Size, By Application, 2018 - 2023 (USD Billion)
Table 45 Asia-Pacific Digital Biomarkers Market Size, By Application, 2025 - 2030 (USD Billion)
Table 46 Asia-Pacific Digital Biomarkers Market Size, By Development Status, 2018 - 2023 (USD Billion)
Table 47 Asia-Pacific Digital Biomarkers Market Size, By Development Status, 2025 - 2030 (USD Billion)
Table 48 Asia-Pacific Digital Biomarkers Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 49 Asia-Pacific Digital Biomarkers Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 50 Asia-Pacific Digital Biomarkers Market Size, by Region, 2018 - 2023 (USD Billion)
Table 51 Asia-Pacific Digital Biomarkers Market Size, by Region, 2025 - 2030 (USD Billion)
Table 52 RoW Digital Biomarkers Market Size, By System Component, 2018 - 2023 (USD Billion)
Table 53 RoW Digital Biomarkers Market Size, By System Component, 2025 - 2030 (USD Billion)
Table 54 RoW Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2023 (USD Billion)
Table 55 RoW Digital Biomarkers Market Size, By Therapeutic Area, 2025 - 2030 (USD Billion)
Table 56 RoW Digital Biomarkers Market Size, By Application, 2018 - 2023 (USD Billion)
Table 57 RoW Digital Biomarkers Market Size, By Application, 2025 - 2030 (USD Billion)
Table 58 RoW Digital Biomarkers Market Size, By Development Status, 2018 - 2023 (USD Billion)
Table 59 RoW Digital Biomarkers Market Size, By Development Status, 2025 - 2030 (USD Billion)
Table 60 RoW Digital Biomarkers Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 61 RoW Digital Biomarkers Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 62 RoW Digital Biomarkers Market Size, by Region, 2018 - 2023 (USD Billion)
Table 63 RoW Digital Biomarkers Market Size, by Region, 2025 - 2030 (USD Billion)
Table 64 Snapshot – AliveCor Labs
Table 65 Snapshot – Eli Lilly and Company
Table 66 Snapshot – Biogen
Table 67 Snapshot – Novartis AG
Table 68 Snapshot – Fitbit LLC
Table 69 Snapshot – GlaxoSmithKline plc
Table 70 Snapshot – F. Hoffmann-La Roche Ltd
Table 71 Snapshot – Koninklijke Philips N.V.
Table 72 Snapshot – Pfizer Inc.
Table 73 Snapshot – Takeda Pharmaceutical Company Limited
List of Figures
Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Digital Biomarkers Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Digital Biomarkers Market Highlight
Figure 12 Global Digital Biomarkers Market Size, By System Component, 2018 - 2030(USD Billion)
Figure 13 Global Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2030(USD Billion)
Figure 14 Global Digital Biomarkers Market Size, By Application, 2018 - 2030(USD Billion)
Figure 15 Global Digital Biomarkers Market Size, By Development Status, 2018 - 2030(USD Billion)
Figure 16 Global Digital Biomarkers Market Size, By End-User, 2018 - 2030(USD Billion)
Figure 17 Global Digital Biomarkers Market Size, by Region, 2018 - 2030(USD Billion)
Figure 18 North America Digital Biomarkers Market Highlight
Figure 19 North America Digital Biomarkers Market Size, By System Component, 2018 - 2030(USD Billion)
Figure 20 North America Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2030(USD Billion)
Figure 21 North America Digital Biomarkers Market Size, By Application, 2018 - 2030(USD Billion)
Figure 22 North America Digital Biomarkers Market Size, By Development Status, 2018 - 2030(USD Billion)
Figure 23 North America Digital Biomarkers Market Size, By End-User, 2018 - 2030(USD Billion)
Figure 24 North America Digital Biomarkers Market Size, by Region, 2018 - 2030(USD Billion)
Figure 25 Europe Digital Biomarkers Market Highlight
Figure 26 Europe Digital Biomarkers Market Size, By System Component, 2018 - 2030(USD Billion)
Figure 27 Europe Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2030(USD Billion)
Figure 28 Europe Digital Biomarkers Market Size, By Application, 2018 - 2030(USD Billion)
Figure 29 Europe Digital Biomarkers Market Size, By Development Status, 2018 - 2030(USD Billion)
Figure 30 Europe Digital Biomarkers Market Size, By End-User, 2018 - 2030(USD Billion)
Figure 31 Europe Digital Biomarkers Market Size, by Region, 2018 - 2030(USD Billion)
Figure 34 Asia-Pacific Digital Biomarkers Market Highlight
Figure 35 Asia-Pacific Digital Biomarkers Market Size, By System Component, 2018 - 2030(USD Billion)
Figure 36 Asia-Pacific Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2030(USD Billion)
Figure 37 Asia-Pacific Digital Biomarkers Market Size, By Application, 2018 - 2030(USD Billion)
Figure 38 Asia-Pacific Digital Biomarkers Market Size, By Development Status, 2018 - 2030(USD Billion)
Figure 39 Asia-Pacific Digital Biomarkers Market Size, By End-User, 2018 - 2030(USD Billion)
Figure 40 Asia-Pacific Digital Biomarkers Market Size, by Region, 2018 - 2030(USD Billion)
Figure 41 RoW Digital Biomarkers Market Highlight
Figure 42 RoW Digital Biomarkers Market Size, By System Component, 2018 - 2030(USD Billion)
Figure 43 RoW Digital Biomarkers Market Size, By Therapeutic Area, 2018 - 2030(USD Billion)
Figure 44 RoW Digital Biomarkers Market Size, By Application, 2018 - 2030(USD Billion)
Figure 45 RoW Digital Biomarkers Market Size, By Development Status, 2018 - 2030(USD Billion)
Figure 46 RoW Digital Biomarkers Market Size, By End-User, 2018 - 2030(USD Billion)
Figure 47 RoW Digital Biomarkers Market Size, by Region, 2018 - 2030(USD Billion)
Global Digital Biomarkers Market Coverage
System Component Insight and Forecast 2025-2030
- Data Collection Tools
- Digital Platforms
- Mobile Apps
- Desktop-Based Software
- Wearable
- Biosensors
- Data Integration Systems
Therapeutic Area Insight and Forecast 2025-2030
- Cardiovascular Diseases
- Neurodegenerative Disorders
- Sleep and Movement Diseases
- Psychiatric Disorders
- Chronic Pain
- Gastrointestinal Diseases
- Diabetes
- Respiratory Diseases
- Others
Application Insight and Forecast 2025-2030
- Wellness
- Disease Diagnosis
- Personalized Medication
- Drug Discovery and Development
Development Status Insight and Forecast 2025-2030
- Novel Digital Biomarkers
- Original Digital Biomarkers
- Approved Digital Biomarkers
End-User Insight and Forecast 2025-2030
- Pharmaceutical Companies & Labs
- Healthcare Providers
- Insurance Payers
Geographical Segmentation
Digital Biomarkers Market by Region
North America
- By System Component
- By Therapeutic Area
- By Application
- By Development Status
- By End-User
- By Country – U.S., Canada, and Mexico
Europe
- By System Component
- By Therapeutic Area
- By Application
- By Development Status
- By End-User
- By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe
Asia-Pacific (APAC)
- By System Component
- By Therapeutic Area
- By Application
- By Development Status
- By End-User
- By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific
Rest of the World (RoW)
- By System Component
- By Therapeutic Area
- By Application
- By Development Status
- By End-User
- By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries
Vynz Research know in your business needs, you required specific answers pertaining to the market, Hence, our experts and analyst can provide you the customized research support on your specific needs.
After the purchase of current report, you can claim certain degree of free customization within the scope of the research.
Please let us know, how we can serve you better with your specific requirements to your research needs. Vynz research promises for quick reversal for your current business requirements.
Purchase Options
Latest Report
Research Methodology
- Desk Research / Pilot Interviews
- Build Market Size Model
- Research and Analysis
- Final Deliverabvle
Connect With Our Sales Team
- Toll-Free: 1 888 253 3960
- Phone: +91 9960 288 381
- Email: enquiry@vynzresearch.com
Digital Biomarkers Market
Global Digital Biomarkers Market – Analysis and Forecast (2025-2030)
- The global digital biomarkers market will grow from USD 0.86 billion to USD 5.4 billion at a CAGR of 22.5%.
- The market is divided by system components, applications, therapeutic area, development status, and end users. All these major segments come with different subsections showing significant growth promises.
- The market growth is primarily attributed to the rise in adoption of connected digital devices, higher use of smartphones and health-related mobile apps, development of wearable devices, a large number of industry players, and more.
- Market growth is hindered due to data privacy and security concerns, strong standardization and validation processes, and regulatory hurdles. However, growth in demand for customized data-driven healthcare solutions and higher investment in wearable technology offer growth opportunities.
- North America leads the market due to a large number of major industry players, higher investment in R&D, more product launches, and higher approval. The Asia Pacific market will grow due to higher government emphasis on healthcare infrastructure development and the use of smart devices.